Abstract
Circulating biomarkers and imaging techniques provide independent and complementary information to guide management of heart failure (HF). This consensus document by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) presents current evidence-based indications relevant to integration of imaging techniques and biomarkers in HF. The document first focuses on application of circulating biomarkers together with imaging findings, in the broad domains of screening, diagnosis, risk stratification, guidance of treatment and monitoring, and then discusses specific challenging settings. In each section we crystallize clinically relevant recommendations and identify directions for future research. The target readership of this document includes cardiologists, internal medicine specialists and other clinicians dealing with HF patients.
Original language | English |
---|---|
Pages (from-to) | 1577-1596 |
Number of pages | 20 |
Journal | European journal of heart failure |
Volume | 23 |
Issue number | 10 |
Early online date | 14 Sept 2021 |
DOIs | |
Publication status | Published - Oct 2021 |
Keywords
- Biomarkers
- Imaging
- Diagnosis
- Management
- Heart failure
- Consensus document
- PRESERVED EJECTION FRACTION
- BRAIN NATRIURETIC PEPTIDE
- SPECKLE-TRACKING ECHOCARDIOGRAPHY
- CARDIOVASCULAR MAGNETIC-RESONANCE
- DIFFUSE MYOCARDIAL FIBROSIS
- LATE GADOLINIUM ENHANCEMENT
- WORSENING RENAL-FUNCTION
- INDIVIDUAL PATIENT DATA
- 2013 ACCF/AHA GUIDELINE
- SUDDEN CARDIAC DEATH